Skip to main content
SpringerLink
Log in

Administration of infliximab by trained general practitioners (GPs) seems to be a “safe and acceptable way” to provide long-term therapy

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Stuby U, Biesenbach G, Pieringer H.Administration of infliximab in general practitioners' offices is safe. Clinical Rheumatology 26: 1863-1866, No. 11, Nov 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Administration of infliximab by trained general practitioners (GPs) seems to be a “safe and acceptable way” to provide long-term therapy. React. Wkly. 1183, 3 (2008). https://doi.org/10.2165/00128415-200811830-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811830-00006

Keywords

Search

Navigation